AKT1 and type 2 diabetes mellitus: Phlorizin has been demonstrated to protect against endothelial dysfunction in T2DM by activating the phosphatidylinositol 3′-kinase (PI3K), Akt, and endothelial nitric oxide synthase (eNOS) (PI3K/Akt/eNOS) signaling pathway [9].